Teligent EBIT 2010-2021 | TLGT
Teligent ebit from 2010 to 2021. Ebit can be defined as earnings before interest and taxes.
Teligent Annual EBIT
(Millions of US $) |
| 2020 |
$-140 |
| 2019 |
$-8 |
| 2018 |
$-15 |
| 2017 |
$-12 |
| 2016 |
$3 |
| 2015 |
$-3 |
| 2014 |
$4 |
| 2013 |
$-0 |
| 2012 |
$-3 |
| 2011 |
$-3 |
| 2010 |
$-4 |
| 2009 |
$-4 |
Teligent Quarterly EBIT
(Millions of US $) |
| 2021-06-30 |
$-11 |
| 2021-03-31 |
$-9 |
| 2020-12-31 |
$-109 |
| 2020-09-30 |
$-9 |
| 2020-06-30 |
$-4 |
| 2020-03-31 |
$-18 |
| 2019-12-31 |
$-6 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
$1 |
| 2019-03-31 |
$-3 |
| 2018-12-31 |
$-5 |
| 2018-09-30 |
$-1 |
| 2018-06-30 |
$-5 |
| 2018-03-31 |
$-4 |
| 2017-12-31 |
$-7 |
| 2017-09-30 |
$-8 |
| 2017-06-30 |
$0 |
| 2017-03-31 |
$3 |
| 2016-12-31 |
$0 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$1 |
| 2016-03-31 |
$1 |
| 2015-12-31 |
$-3 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$-2 |
| 2015-03-31 |
$1 |
| 2014-12-31 |
$4 |
| 2014-09-30 |
$-0 |
| 2014-06-30 |
$-0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$-0 |
| 2013-06-30 |
$-0 |
| 2013-03-31 |
$-0 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-1 |
| 2012-03-31 |
$-1 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-0 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-1 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-1 |
| 2010-03-31 |
$-1 |
| 2009-12-31 |
$-1 |
| 2009-09-30 |
$-1 |
| 2009-06-30 |
$-1 |
| 2009-03-31 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
